219 related articles for article (PubMed ID: 21703227)
1. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
[TBL] [Abstract][Full Text] [Related]
2. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
Shafa M; Krawetz R; Rancourt DE
Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells' self-renewal and pluripotency is maintained by a bovine granulosa cell line-conditioned medium.
Solari C; Losino N; Luzzani C; Waisman A; Bluguermann C; Questa M; Sevlever G; Miriuka S; Barañao L; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(2):252-7. PubMed ID: 21651896
[TBL] [Abstract][Full Text] [Related]
4. Computer and statistical analysis of transcription factor binding and chromatin modifications by ChIP-seq data in embryonic stem cell.
Orlov Y; Xu H; Afonnikov D; Lim B; Heng JC; Yuan P; Chen M; Yan J; Clarke N; Orlova N; Huss M; Gunbin K; Podkolodnyy N; Ng HH
J Integr Bioinform; 2012 Sep; 9(2):211. PubMed ID: 22987856
[TBL] [Abstract][Full Text] [Related]
5. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells.
Kidder BL; Palmer S; Knott JG
Stem Cells; 2009 Feb; 27(2):317-28. PubMed ID: 19056910
[TBL] [Abstract][Full Text] [Related]
6. Defining pluripotent stem cells through quantitative proteomic analysis.
Reiland S; Salekdeh GH; Krijgsveld J
Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
[TBL] [Abstract][Full Text] [Related]
7. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
8. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
[TBL] [Abstract][Full Text] [Related]
9. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated embryonic cell transcription factor 1 regulates ESC chromatin organization and gene expression.
Kooistra SM; van den Boom V; Thummer RP; Johannes F; Wardenaar R; Tesson BM; Veenhoff LM; Fusetti F; O'Neill LP; Turner BM; de Haan G; Eggen BJ
Stem Cells; 2010 Oct; 28(10):1703-14. PubMed ID: 20715181
[TBL] [Abstract][Full Text] [Related]
11. Ly-1 antibody reactive clone is an important nucleolar protein for control of self-renewal and differentiation in embryonic stem cells.
Li H; Wang B; Yang A; Lu R; Wang W; Zhou Y; Shi G; Kwon SW; Zhao Y; Jin Y
Stem Cells; 2009 Jun; 27(6):1244-54. PubMed ID: 19489080
[TBL] [Abstract][Full Text] [Related]
12. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells.
Ambrosi DJ; Tanasijevic B; Kaur A; Obergfell C; O'Neill RJ; Krueger W; Rasmussen TP
Stem Cells; 2007 May; 25(5):1104-13. PubMed ID: 17272499
[TBL] [Abstract][Full Text] [Related]
14. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
[TBL] [Abstract][Full Text] [Related]
15. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
16. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
18. Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming.
Singhal N; Graumann J; Wu G; Araúzo-Bravo MJ; Han DW; Greber B; Gentile L; Mann M; Schöler HR
Cell; 2010 Jun; 141(6):943-55. PubMed ID: 20550931
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
[TBL] [Abstract][Full Text] [Related]
20. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
